A case series of invasive pneumococcal disease in children

Authors

  • Baburaj B. Department of Paediatrics, Pushpagiri Institute of Medical Science and Research Centre, Thiruvalla, Kerala, India
  • Carol Sara Cherian Department of Paediatrics, Pushpagiri Institute of Medical Science and Research Centre, Thiruvalla, Kerala, India
  • Jacob Abraham Department of Paediatrics, Pushpagiri Institute of Medical Science and Research Centre, Thiruvalla, Kerala, India
  • Aneeta Mary Jacob Department of Microbiology, Pushpagiri Institute of Medical Science and Research Centre, Thiruvalla, Kerala, India

DOI:

https://doi.org/10.18203/2349-3291.ijcp20231505

Keywords:

Streptococcus pneumoniae, IPD, Pediatric, Case series, Developing countries

Abstract

Invasive pneumococcal disease (IPD) has a high clinical burden, particularly among children in developing countries.  We presented 4 cases of IPD in children who were admitted to Pushpagiri institute of medical science and research centre, Kerala between 2021 and 2022. While our first 3 patients had milder course of disease, our fourth patient who presented with severe pneumonia with pleural effusion had poor outcome. The fact that three out of four of our patients have not received pneumococcal vaccination marks the necessity of this vaccine to prevent IPD in children.

 

Metrics

Metrics Loading ...

References

Kliegman RM, St. Geme J. Nelson textbook of paediatrics 21st edition, chapter 209. 2023;5812-25.

O’Brien KL, Greenbaum A. Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000-15. Lancet Glob Health. 2018;6(7):e744-57.

WHO. Surveillance Standards for Vaccine-Preventable Diseases. 2nd ed. World Health Organization. 2018.

Arguni E, Wijaya CS, Indrawanti R, Laksono IS, Ishiwada N. Pediatric Invasive pneumococcal Disease (IPD) in Yogyakarta, Indonesia: A Case Series. Glob Pediatr Health. 2022;9:2333794X221108963.

National operational guidelines, Introduction of pneumococcal conjugate vaccine, Division Ministry of Health and Family Welfare, Government of India. 2021.

Feldman C, Anderson R. Bacteraemic pneumococcal Pneumonia. Drugs. 2011;71:131-53.

Dockrell DH, Whyte MK, Mitchell TJ. pneumococcal Pneumonia. Chest. 2012;142:482-91.

Demirdal T, Sen P, Emir B. Predictors of mortality in invasive pneumococcal disease: A meta-analysis. Expert Rev. Anti Infect Ther. 2020;31:1-18.

Burgos J, Lujàn M, Larrosa MN, Fontanals D, Bermudo G, Planes AM et al. Risk factors for respiratory failure in pneumococcal pneumonia: The importance of pneumococcal serotypes. Eur Respir J. 2014;43:545-53.

Downloads

Published

2023-05-26

How to Cite

B., B., Cherian, C. S., Abraham, J., & Jacob, A. M. (2023). A case series of invasive pneumococcal disease in children. International Journal of Contemporary Pediatrics, 10(6), 939–942. https://doi.org/10.18203/2349-3291.ijcp20231505

Issue

Section

Case Series